Mural Oncology plc most recently reported annual revenue of $0, a net loss of $129.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Mural Oncology plc: net profit was positive in 0 of 4 reported years; the most recent year shows a net loss of $129.0M.
Income Statement — 4 Years (USD millions)
Metric
2021
2022
2023
2024
Revenue
$0
$0
$0
$0
Operating Expenses
$175.0M
$185.0M
$195.0M
$138.0M
Operating Profit
$-175.0M
$-185.0M
$-195.0M
$-138.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
Other Income
$0
$0
$-1.0M
$10.0M
Interest
$0
$0
$0
$0
Depreciation
$1.0M
$2.0M
$3.0M
$4.0M
Profit Before Tax
$-175.0M
$-185.0M
$-195.0M
$-129.0M
Tax
$-40,000
$-2.6M
$-6.2M
$0
Net Profit
$-175.0M
$-190.0M
$-207.0M
$-129.0M
EPS
$-10.51
$-11.37
$-12.43
$-7.58
Dividend Payout
0.0%
0.0%
0.0%
0.0%
Quarterly Results — Last 12 Quarters (USD millions)
1 duplicate period label in the source data were collapsed.
Metric
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Operating Expenses
$58.0M
$44.0M
$47.0M
$45.0M
$59.0M
$34.0M
$34.0M
$34.0M
$36.0M
$34.0M
$31.0M
$4.0M
Operating Profit
$-58.0M
$-44.0M
$-47.0M
$-45.0M
$-59.0M
$-34.0M
$-34.0M
$-34.0M
$-36.0M
$-34.0M
$-31.0M
$-4.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Interest
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Profit Before Tax
$-58.0M
$-44.0M
$-47.0M
$-46.0M
$-58.0M
$-31.0M
$-32.0M
$-32.0M
$-34.0M
$-33.0M
$-48.0M
$-4.0M
Tax
$-2.1M
$-5.2M
$-6.2M
$-10.7M
$-3.4M
$0
$0
$0
$0
$0
$0
$0
Net Profit
$-59.0M
$-46.0M
$-50.0M
$-51.0M
$-60.0M
$-31.0M
$-32.0M
$-32.0M
$-34.0M
$-33.0M
$-48.0M
$-4.0M
EPS
$-3.52
$-2.78
$-3.13
$-3.07
$-3.57
$-1.84
$-1.86
$-1.87
$-2.01
$-1.93
$-2.78
$-0.21
Over the 4 years reported for Mural Oncology plc, borrowings decreased from $25.0M in 2021 to $8.0M in 2024, cash stood at $115.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 5.88 times.
Balance Sheet — 4 Years (USD millions)
Metric
2021
2022
2023
2024
Total Assets
$35.0M
$34.0M
$302.0M
$169.0M
Current Assets
$4.0M
$5.0M
$277.0M
$153.0M
Cash
$0
$0
$271.0M
$115.0M
Inventory
$0
$0
$0
$0
Receivables
$0
$0
$6.0M
$0
Fixed Assets
$31.0M
$29.0M
$24.0M
$14.0M
Capital Work in Progress
$0
$0
$0
$0
Investments
$0
$0
$0
$29.0M
Other Assets
$0
$0
$0
$0
Total Liabilities
$53.0M
$55.0M
$38.0M
$29.0M
Current Liabilities
$33.0M
$42.0M
$29.0M
$26.0M
Borrowings
$25.0M
$19.0M
$15.0M
$8.0M
Other Liabilities
$28.0M
$36.0M
$23.0M
$21.0M
Equity
$-18.0M
$-22.0M
$0
$0
Reserves
$-18.0M
$-22.0M
$264.0M
$141.0M
For Mural Oncology plc, operating cash flow was positive in 0 of 4 reported years; free cash flow in the latest year was negative at $129.0M; free cash flow was positive in 0 of 4 years.